1. sayfa ve
Tekrarlanan kayıtlar tek bir kaynakta birleştirilmektedir.
1
Veriseti
Veriseti
Kaynak
:
Yazar(lar) :
Yıl :
2020
Fr-SARS-CoV-2 Tentative de classement du nombre de cas confirmés du virus
SARS-
CoV-
2 sur le territoire français par régions.Les données sont issues des médias et /article/points-de-situation-
coronavirus-
covid-
19- https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-
coronavirus /articles/infection-au-nouveau-
coronavirus-
sars-
cov-
2-
covid-
19-france-et-monde- https://france3-regions.francetvinfo.fr- https://www.ars.sante.fr/- https sars cov 2 coronavirus covid 19
2
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
New Coronavirus COVID-19 (SARS-CoV-2) covid-19 (sars-cov-2)
3
e-Kitap
e-Kitap
Kaynak
:
Dergi:
Yayıncı:
Internet Archive
Yazar(lar) :
Yıl :
2020
Studies Investigating Potential Inhibitors of Novel Coronavirus (SARS-CoV-2) COVID-19 Emergence of
COVID-
19 in China in late 2019 has now lead to a global pandemic.
4
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Wei E. Huang
,
Boon Lim
,
Chiau2010Chen Hsu
,
Dan Xiong
,
Wei Wu
,
Yejiong Yu
,
Huidong Jia
,
Yun Wang
,
Yida Zeng
,
Mengmeng Ji
,
Hong Chang
,
Xiuming Zhang
,
Hui Wang
,
Zhanfeng Cui
Yıl :
2020
RT‐LAMP for rapid diagnosis of coronavirus SARS‐CoV‐2 Summary The pandemic
coronavirus
SARS‐
CoV‐
2 in the world has caused a large infected population suffering from
COVID‐
19. We applied a reverse transcription‐loop‐mediated isothermal amplification (RT‐LAMP) to achieve the detection of
SARS‐
CoV‐
2 in 30 min. We designed four sets of LAMP primers (6 primers in each set), targeting the viral RNA of
SARS‐
CoV‐
2 in the regions of orf1ab, S gene and N gene.
5
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
Novel Coronavirus (SARS-CoV-2) Pandemic: Overview and Current Status The disease was later named as
COVID-
19 (
coronavirus disease 2019) and the causative agent was designated as
SARS-
CoV-
2 (severe acute respiratory syndrome coronavirus
2). The knowledge on the characteristics and epidemiology of
SARS-
CoV-
2 and
COVID-
19 has been increasing day by day. severe acute respiratory syndrome coronavirus 2 sars-cov-2 covid-19
6
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Impact of SARS-CoV-2 (Coronavirus) Pandemic on Public Mental Health SARS-CoV-2 COVID-19
7
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Coronavirus-SARS-CoV-2: Biology and Problems in rRT-PCR Detection Coronavirus disease 2019 (
COVID-
19) first appeared in China in December 2019 and was declared a pandemic by the World Health Organization. COVID-
19 is caused by Severe Acute Respiratory Syndrome Corona Virus
2 (
SARS-
CoV-
2), a new virus previously unknown to humans. covid-19 sars-cov-2
8
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
Modeling the Novel Coronavirus (SARS-CoV-2) Outbreak in Sicily, Italy (
SARS-
CoV-
2) in all its regions. While such efforts are still ongoing, uncertainties regarding
SARS-
CoV-
2 transmissibility and ascertainment of cases make it difficult to evaluate the Overall, we obtained a good fit between estimated and reported data, with a fraction of unreported
SARS-
CoV-
2 cases (18.4%; 95%CI = 0–34.0%) before 10 novel coronavirus COVID-19
9
Dergi Makalesi
Dergi Makalesi
Kaynak
1:
Kaynak
2:
Dergi:
Yazar(lar) :
Yıl :
2020
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2 The recent outbreak of the
Coronavirus disease 2019 (
COVID-
19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. -
19. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of
COVID-
19. COVID-19 SARS-CoV-2
10
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Management of the SARS-CoV-2 (COVID-19) coronavirus epidemic in hemodialysis units The current outbreak of
SARS-
CoV-
2 represents a special risk for renal patients due to their comorbidities and advanced age. particular in hemodialysis units, with the objective of early identification of patients who meet the definition of a suspected case of infection by
SARS-
CoV Resumen: La epidemia de
SARS-
CoV-
2 representa un riesgo especial para los pacientes renales por su condición de personas con comorbilidades y edad avanzada SARS-CoV-2 COVID-19 Coronavirus
11
Dergi Makalesi
Dergi Makalesi
Kaynak
:
Yayıncı:
ORA - Oxford University Research Archive
Yazar(lar) :
Yıl :
2020
RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2 The pandemic
coronavirus
SARS‐
CoV‐
2 in the world has caused a large infected population suffering from
COVID‐
19. We applied a reverse transcription‐loop‐mediated isothermal amplification (RT‐LAMP) to achieve the detection of
SARS‐
CoV‐
2 in 30 min. We designed four sets of LAMP primers (6 primers in each set), targeting the viral RNA of
SARS‐
CoV‐
2 in the regions of orf1ab, S gene and N gene. sars-cov-2 virus covid-19
12
Dergi Makalesi
Dergi Makalesi
Dergi:
Yıl :
2020
Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus COVID-19 Sars-CoV-2 coronavirus
13
Derleme Makalesi
Derleme Makalesi
Kaynak
:
Yayıncı:
Springer Link
Yazar(lar) :
Konu :
nternal Medicine, Infectious Diseases
Yıl :
2020
Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains The emergence of the strain of
coronavirus
SARS-
CoV-
2 (severe acute respiratory syndrome
coronavirus
2) and its impact on global health have made imperative SARS-
CoV-
2 now adds to the list of
coronavirus diseases that have threatened global health, along with the
SARS (severe acute respiratory syndrome) and Nevertheless, the knowledge obtained from the vaccine development efforts for MERS and
SARS can be of high value for
COVID-
19 (
coronavirus disease 2019 Coronavirus COVID-19 SARS
14
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
Información preliminar de las características virológicas del nuevo coronavirus SARS-CoV-2 En diciembre de 2019 surgió en China un nuevo
coronavirus, conocido como
SARS-
CoV-
2 y causante de la enfermedad
COVID-
19. SARS-
CoV que apareció a comienzo de este siglo en China y el MERS-
CoV que surgió en Arabia en 2012. SARS-
CoV-
2 empezó a propagarse en un mercado de la ciudad de Wuhan (China) donde se vendían pescados, mariscos y diferentes animales vivos. sars-cov-2 novel coronavirus covid-19
15
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far They were caused by a previously unknown
coronavirus. Based on clinical criteria and available serological and molecular information, the new disease was called
coronavirus disease of 2019 (
COVID-
19), and the novel
coronavirus was called
SARS
Coronavirus-
2 (
SARS-
CoV-
2), emphasizing its close relationship to the 2002
SARS virus (
SARS-
CoV). coronavirus covid-19 sars-cov-2
16
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Coronavirus (SARS-CoV-2) and Mortality Rate in India: The Winning Edge COVID-19
17
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Repercusión cardiovascular de la infección por el nuevo coronavirus SARS-CoV-2 (COVID-19) Repercusión cardiovascular de la infección por el nuevo
coronavirus
SARS-
CoV-
2 (
COVID-
19)
18
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Ping Liu
,
Jing-Zhe Jiang
,
Xiu-Feng Wan
,
Yan Hua
,
Linmiao Li
,
Jiabin Zhou
,
Xiaohu Wang
,
Fanghui Hou
,
Jing Chen
,
Jiejian Zou
,
Jinping Chen
Yıl :
2020
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? Recent studies showed that
SARS-
CoV-
2 was likely originated from bats, but its intermediate hosts are still largely unknown. The molecular and phylogenetic analyses showed that this pangolin
coronavirus (pangolin-
CoV-2020) is genetically related to the
SARS-
CoV-
2 as well as a group of bat coronaviruses but do not support the
SARS-
CoV-
2 emerged directly from the pangolin-
CoV-2020.
19
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
SARS-CoV-2(COVID-19) infections ranging from the common cold associated with HKU1, NL63, OC43 and 229E viruses to more severe diseases such as Severe Acute Respiratory Syndrome (
SARS ) during 2002, Middle East Respiratory Syndrome (MERS) during 2012, and the
COVID-
19 that started during December 2019 in Wuhan, China.
20
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
A Preventive Role of Exercise Across the Coronavirus 2 (SARS-CoV-2) Pandemic The
coronavirus 2019 (
COVID-
19) pandemic has posed a significant threat to human health around the world. In addition, individuals with obesity and obesity-related comorbidities have also been identified to be at a higher risk of infection for
COVID-
19. -
19. coronavirus 2019
21
Dergi Makalesi
Dergi Makalesi
Dergi:
Yayıncı:
NISCAIR-CSIR, India
Yazar(lar) :
Yıl :
2020
Is SARS-CoV-2 Airborne? While we are now past the first six months of the
COVID-
19 pandemic, some new ideas of the transmission of
SARS-
CoV-
2 have begun to emerge.
22
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks Coronaviruses (CoVs) are RNA viruses that have become a major public health concern since the Severe Acute Respiratory Syndrome-
CoV (
SARS-
CoV) outbreak Currently, the world is concerned about the 2019 novel
CoV (
SARS-
CoV-
2) that was initially identified in the city of Wuhan, China in December 2019. Although the fatality rate of
SARS-
CoV-
2 is currently lower than
SARS-
CoV, the virus seems to be highly contagious based on the number of infected cases sars-cov-2 covid-19
23
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
Indirect exposure to novel coronavirus (SARS-CoV-2): an overview of current knowledge Current knowledge of transmission and exposure of
SARS-
CoV-
2 has been explained. covid-19
24
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Coronavirus Pandemic (SARS-COV-2): Pre-Exercise Screening Questionnaire (PESQ) for Telepresential Exercise COVID-19
25
Araştırma Makalesi
Araştırma Makalesi
Kaynak
:
Dergi:
Yazar(lar) :
Yıl :
2020
SARS-CoV-2 neutralizing antibody development strategies Owing to a high rate of transmission from human to human, the new virus called
SARS-
CoV-
2 differed from others by its unexpectedly rapid spread. No approved targeted-therapies are available for
COVID-
19, yet. This review aims to provide some of the neutralizing antibody development strategies for
SARS-
CoV-
2 and in vitro and in vivo neutralization assays.
26
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections The newly discovered
SARS-
CoV-
2 (2019-nCoV) is responsible for the third
coronavirus pandemic in the human population, and this virus exhibits enhanced SARS-
CoV-
2 is highly genetically homologous to
SARS-
CoV, and infection may result in a similar clinical disease (
COVID-
19). the clinical features and potential immunopathogenesis of
COVID-
19. novel coronavirus SARS-CoV-2 SARS-CoV
27
Dergi Makalesi
Dergi Makalesi
Yazar(lar) :
Yıl :
2020
SARS-CoV-2 and COVID-19
28
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Manejo de la epidemia por coronavirus SARS-CoV-2 (COVID-19) en unidades de hemodiálisis Resumen: La epidemia de
SARS-
CoV-
2 representa un riesgo especial para los pacientes renales por su condición de personas con comorbilidades y edad avanzada unidades de hemodiálisis, con el objetivo de identificar precozmente a los pacientes que cumplan con la definición de caso sospechoso de infección por el
SARS-
CoV Abstract: The current outbreak of
SARS-
CoV-
2 represents a special risk for renal patients due to their comorbidities and advanced age. SARS-CoV-2 COVID-19 Coronavirus
29
Dergi Makalesi
Dergi Makalesi
Dergi:
Yazar(lar) :
Yıl :
2020
Genetic Analysis of the Coronavirus SARS-CoV-2 Host Protease TMPRSS2 in Different Populations COVID-19 SARS-CoV-2